Desk›Healthcare› 3B BlackBio Dx Ltd
3B BlackBio Dx Ltd
BSE 532067 · NSE 3BBLACKBIO · ISIN INE994E01018 · Group B · Active
Healthcare › Healthcare › Healthcare Services › Healthcare Service Provider
₹1,354.75
+3.70%
BSE close, 28 August 2026
₹1,162.74 cr
0.9 cr shares · Micro cap
₹672.23 cr
as published
22.8× · 4.65×
EPS ₹59.38 · BV ₹291.34
97.28 / 49.32
₹ cr, as filed
22
4 selected · 18%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -22.6% |
|---|---|
| Against 52-week low | +25.0% |
| Day change | +3.70% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹59.38 |
|---|---|
| Price / earnings | 22.81× |
| Price / book | 4.65× |
| Book value — derived, price ÷ P/B | ₹291.34 |
| Return on equity | 20.38% |
| Operating margin | 81.01% |
| Net margin | 61.50% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 20.39%
- ROE as published
- 20.38%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 22.95 | 14.11 | 16.47 | 81.01% | 61.50% |
| Mar-26 · Q | 24.63 | 7.45 | 8.69 | 51.10% | 30.24% |
| FY25-26 | 97.28 | 49.32 | 57.56 | 69.23% | 50.70% |
Quarter on quarter
- Revenue, quarter on quarter
- -6.8%
- Net profit, quarter on quarter
- +89.4%
- Operating margin, quarter on quarter
- +2,991 bps
Disclosure profile 22 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Management | 1 |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 4 |
| Procedural | |
| AGM / EGM | 6 |
| Analyst / Investor Meet | 4 |
| Newspaper Publication | 3 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| General | 1 |
| Trading Window | 1 |
| Procedural sub-total | 18 |
| Total | 22 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
22 filings · 4 selected · busiest 2026-09-07
Filing rhythm · the twelve most recent
2026-09-072026-10-09
SelectedProcedural
Filings
22 in the window · 8 earlier on record
-
9 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 September 2026 ·
Change in Management
Re-appointment of director who retires by rotation and being eligible, offers for re-appointment
Company Update / Change in Management View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer's Report and Voting report for 54th AGM
AGM/EGM / AGM View filing →
-
29 September 2026 ·
-
25 September 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
18 September 2026 ·
Newspaper Publication
Special Window for Re-lodgement of Transfer Requests of Physical shares
Company Update / Newspaper Publication View filing →
-
16 September 2026 ·
Analyst / Investor Meet - Outcome
Analyst/Investor Meet- Outcome
Company Update / Analyst / Investor Meet View filing →
-
11 September 2026 ·
Analyst / Investor Meet - Intimation
Analyst/Investor Meet intimation
Company Update / Analyst / Investor Meet View filing →
-
11 September 2026 ·
Analyst / Investor Meet - Outcome
Analyst/ Investor Meet Outcome
Company Update / Analyst / Investor Meet View filing →
-
8 September 2026 ·
-
7 September 2026 ·
-
7 September 2026 ·
Annual General Meeting To Be Held On 29Th September, 2026
Annual General Meeting to be held on 29th September, 2026
AGM/EGM / AGM View filing →
-
7 September 2026 ·
-
7 September 2026 ·
Record Date And Date Of Book Closure For The Purpose Of Dividend And AGM
Record date and date of book closure for the purpose of Dividend and AGM
AGM/EGM / AGM View filing →
-
7 September 2026 ·
Reg. 34 (1) Annual Report.
Reg 34 (1) Annual Report FY 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
7 September 2026 ·
Annual General Meeting To Be Held On 29Th September, 2026
Notice of Annual General Meeting to be held on 29th September, 2026
AGM/EGM / AGM View filing →
-
25 August 2026 ·
Analyst / Investor Meet - Intimation
Analyst/ Investor Meet Intimation
Company Update / Analyst / Investor Meet View filing →
-
14 August 2026 ·
Newspaper Publication
Newspaper Publication of Unaudited Financial Results for the quarter ended 30th June, 2026
Company Update / Newspaper Publication View filing →
-
13 August 2026 ·
-
13 August 2026 ·
Unaudited Financial Results For The Quarter Ended 30Th June, 2026
Unaudited Financial Results for the quarter ended 30th June, 2026
Result / Financial Results View filing →
-
13 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting held on 13th August, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
5 August 2026 ·
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The First Quarter Ended 30Th June, 2026.
3B Blackbio Dx Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....
Board Meeting / Board Meeting View filing →
RSS feed for 3B BlackBio Dx Ltd · the 50 most recent filings